top of page
Live attenuated tetravalent vaccine (Qdenga) against all four dengue virus serotypes.
Pricing
£105 per dose
Age Eligibility
From 4 years
Administration
2 subcutaneous injections given 3 months apart.
Booster
Not currently established.
Possible Side effects
Fever, injection site pain, headache, fatigue.
Certificate required
No
Risk if Contracted
Aftercare
Severe dengue may cause internal bleeding, shock, or death.
Monitor for fever, rest, hydration.
Additional Information
Recommended for travellers with prior dengue exposure going to endemic areas.
bottom of page